NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.

NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.
复制标题

DOI:
10.6004/jnccn.2022.0058
复制
发表时间:
2022-11
期刊:
Journal of the National Comprehensive Cancer Network : JNCCN
影响因子:
--
通讯作者:
Hang LE
Hang LE
中科院分区:
其他
文献类型:
--
作者:
von Mehren M;Kane JM;Riedel RF;Sicklick JK;Pollack SM;Agulnik M;Bui MM;Carr-Ascher J;Choy E;Connelly M;Dry S;Ganjoo KN;Gonzalez RJ;Holder A;Homsi J;Keedy V;Kelly CM;Kim E;Liebner D;McCarter M;McGarry SV;Mesko NW;Meyer C;Pappo AS;Parkes AM;Petersen IA;Poppe M;Schuetze S;Shabason J;Spraker MB;Zimel M;Bergman MA;Sundar H;Hang LE

文献摘要

参考文献

被引文献

相似文献

胃肠道间质瘤(GIST)是发生在整个胃肠道的最常见的软组织肉瘤类型。大多数这些肿瘤是由 KIT 或 PDGFRA 基因的致癌激活突变引起的。 NCCN GIST 指南为这些肿瘤患者的诊断、评估、治疗和随访提供了建议。这些 NCCN 指南见解总结了指南最近重要更新背后的小组讨论,包括根据突变状态对不可切除、进行性或转移性 GIST 进行修订的全身治疗方案,以及对特定酪氨酸激酶抑制剂产生耐药性的 GIST 管理的更新建议。
Gastrointestinal stromal tumors (GIST) are the most common type of soft tissue sarcoma that occur throughout the gastrointestinal tract. Most of these tumors are caused by oncogenic activating mutations in the KIT or PDGFRA genes. The NCCN Guidelines for GIST provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with these tumors. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including revised systemic therapy options for unresectable, progressive, or metastatic GIST based on mutational status, and updated recommendations for the management of GIST that develop resistance to specific tyrosine kinase inhibitors.
DOI: 10.1002/gcc.20589
发表时间: 2008-10
影响因子: 3.7
作者:
Agaram, Narasimhan P.;Wong, Grace C.;Guo, Tianhua;Maki, Robert G.;Singer, Samuel;DeMatteo, Ronald P.;Besmer, Peter;Antonescu, Cristina R.
通讯作者: Antonescu, Cristina R.
DOI: 10.1200/jco.2004.05.140
发表时间: 2004-09-15
影响因子: 45.3
作者:
Corless, CL;Fletcher, JA;Heinrich, MC
通讯作者: Heinrich, MC
DOI: 10.1016/j.ejca.2003.11.025
发表时间: 2004-03-01
影响因子: 8.4
作者:
Debiec-Rychter, M;Dumez, H;van Oosterom, AT
通讯作者: van Oosterom, AT
DOI: 10.3892/ol.2013.1408
发表时间: 2013-08
期刊: Oncology letters
影响因子: 2.9
作者:
Kefeli U;Benekli M;Sevinc A;Yildiz R;Kaplan MA;Ciltas A;Balakan O;Isikdogan A;Coskun U;Dane F;Harputluoglu H;Karaca H;Yazilitas D;Durnali A;Kaya AO;Demirci U;Gumus M;Buyukberber S
通讯作者: Buyukberber S
DOI: 10.1093/annonc/mdw228
发表时间: 2016-09-01
期刊: ANNALS OF ONCOLOGY
影响因子: 50.5
作者:
Ben-Ami, E.;Barysauskas, C. M.;George, S.
通讯作者: George, S.